-
1
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience
Published 2023-09-01Subjects: Get full text
Article -
2
Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
Published 2022-03-01Subjects: Get full text
Article -
3
Setting for “Normal” Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy
Published 2021-12-01Subjects: Get full text
Article -
4
The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
Published 2021-11-01Subjects: Get full text
Article -
5
Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
Published 2023-02-01Subjects: Get full text
Article -
6
Pancreatic T2* Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia
Published 2023-09-01“…We considered 813 TDT patients (36.47 ± 10.71 years, 54.6% females) enrolled in the Extension-Myocardial Iron Overload in Thalassemia Network. MRI was used to measure hepatic, pancreatic, and cardiac iron overload (IO), to assess biventricular function and atrial dimensions, and to detect replacement myocardial fibrosis. …”
Get full text
Article -
7
Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia
Published 2024-02-01“…CMR was used to quantify cardiac iron overload, biventricular function, and atrial dimensions, and to detect left ventricular (LV) replacement fibrosis. …”
Get full text
Article -
8
Random Forest Clustering Identifies Three Subgroups of β-Thalassemia with Distinct Clinical Severity
Published 2022-02-01“…Cluster 3 represented patients with early initiation of transfusion and iron chelation, considerable iron overload, and early mortality from heart failure. …”
Get full text
Article -
9
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
Published 2022-12-01“…Management of anemia with regular blood transfusions is associated with complications including iron overload. Here, we report long-term safety and efficacy results of the first clinical study of luspatercept in β-thalassemia, initiated in 2013, enrolling adults with both nontransfusion-dependent (NTD) and transfusion-dependent (TD) β-thalassemia. …”
Get full text
Article